Clinical trial
Effectiveness of Intravenous Tranexamic Acid in Primary Cerebral Hemorrhage for Prevention of Hematoma Progression: Protocol for a Randomized, Double Blind Placebo-controlled Trial
NCT04742205 is registered in ClinicalTrials.gov with Kathmandu Medical College and Teaching Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Intravenous Tranexamic Acid in Primary Cerebral Hemorrhage for Prevention of Hematoma Progression: Protocol for a Randomized, Double Blind Placebo-controlled Trial
- Lead sponsor
- Kathmandu Medical College and Teaching Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 8, 2021
- Completion date
- June 4, 2024
- Enrollment
- 154 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.